PHAS
Barclays’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-197
| Closed | – | – | 4635 |
|
|
2022
Q4 | $0 | Hold |
197
| – | – | ﹤0.01% | 4780 |
|
|
2022
Q3 | $0 | Hold |
197
| – | – | ﹤0.01% | 4960 |
|
|
2022
Q2 | $0 | Sell |
197
-31,698
| -99% | – | ﹤0.01% | 5093 |
|
|
2022
Q1 | $43K | Buy |
31,895
+2,181
| +7% | +$2.94K | ﹤0.01% | 4065 |
|
|
2021
Q4 | $78K | Sell |
29,714
-2,909
| -9% | -$7.64K | ﹤0.01% | 2992 |
|
|
2021
Q3 | $101K | Sell |
32,623
-1,147
| -3% | -$3.55K | ﹤0.01% | 3217 |
|
|
2021
Q2 | $126K | Buy |
33,770
+21,016
| +165% | +$78.4K | ﹤0.01% | 3062 |
|
|
2021
Q1 | $45K | Buy |
12,754
+7,831
| +159% | +$27.6K | ﹤0.01% | 3542 |
|
|
2020
Q4 | $16K | Sell |
4,923
-5,427
| -52% | -$17.6K | ﹤0.01% | 3404 |
|
|
2020
Q3 | $36K | Sell |
10,350
-7,175
| -41% | -$25K | ﹤0.01% | 3391 |
|
|
2020
Q2 | $80K | Buy |
17,525
+6,890
| +65% | +$31.5K | ﹤0.01% | 3213 |
|
|
2020
Q1 | $35K | Sell |
10,635
-11,334
| -52% | -$37.3K | ﹤0.01% | 3230 |
|
|
2019
Q4 | $134K | Buy |
21,969
+6,403
| +41% | +$39.1K | ﹤0.01% | 3350 |
|
|
2019
Q3 | $65K | Sell |
15,566
-10,692
| -41% | -$44.6K | ﹤0.01% | 3599 |
|
|
2019
Q2 | $344K | Buy |
26,258
+19,958
| +317% | +$261K | ﹤0.01% | 2925 |
|
|
2019
Q1 | $60K | Buy |
+6,300
| New | +$60K | ﹤0.01% | 3574 |
|